Hanseatic Management Services Inc Vericel Corp Transaction History

Hanseatic Management Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$35.2 - $52.6 $482,979 - $721,724	-13,721 Closed	0 $0
Q3 2021 Oct 05, 2021	BUY	$46.35 - $59.75 $54,461 - $70,206	1,175 Added 9.37%	13,721 $670,000
Q2 2021 Jul 30, 2021	BUY	$47.2 - $67.81 $19,116 - $27,463	405 Added 3.34%	12,546 $659,000
Q1 2021 May 11, 2021	BUY	$30.93 - $59.48 $375,521 - $722,146	12,141 New	12,141 $674,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.